Intestinal Serotonergic Vagal Signaling as a Mediator of Microbiota-Induced Hypertension

The authors investigate the role of intestinal serotonergic vagal signaling in mediating the relationship between gut microbiota and hypertension. They find that reduced intestinal serotonin levels and vagal 5HT3a receptor signaling are linked to hypertension in both rats and humans, suggesting that restoring this signaling pathway may offer a novel therapeutic approach for resistant hypertension associated with gut dysbiosis. This study enhances understanding of the mechanisms underlying hypertension and highlights the gut-brain axis as a potential target for treatment.